Pulmonary hypertension and valvular heart disease
Tobias Tichelbäcker(University of Cologne), Stephan Rosenkranz(University of Cologne), Christian Frerker(University Hospital Schleswig-Holstein), Roman Pfister(University of Cologne), D. Dumitrescu(Heart and Diabetes Center North Rhine-Westphalia), Stephan Baldus(University of Cologne), Felix Gerhardt, Max Wißmüller, Marcel Halbach, Tobias Schmidt(Asklepios Fachklinikum Brandenburg), Matti Adam(Klinik und Poliklinik für Psychosomatik und Psychotherapie), Daniel Stern
Cited by 40
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
|Circulation|2003|1k
Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction
|JAMA|2011|508
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|486